Aquarius Surgical Technologies Inc.
Aquarius Provides an Update on the Anticipated Delay in Filing of Annual Financial Results for the Year Ended March 31, 2021
TORONTO, ON / ACCESSWIRE / July 20, 2021 / Aquarius Surgical Technologies Inc. (CSE:ASTI)(the "Company") announces an update to the Press Release issued on July 19, 2021, when it announced that there is an anticipated delay in filing Annual Financial Results for the year ended March 31, 2021, and that an Application was being made to the Ontario Securities Commission for a Management Cease Trade Order pursuant to National Policy 12-203.
The Company has been notified by the Ontario Securities Commission that a Management Cease Trade Order will not be issued, and that unless the Audited Annual Financial Statements, the Management's Discussion & Analysis and related CEO and CFO Certificates for the year ended March 31, 2021 (the "Annual Filings") are not filed by July 29, 2021 (the "Regulatory Filing Deadline"), then a Cease Trade Order will be issued.
While the Company anticipates that it will not be able to complete the filing of Annual Filings by the Regulatory Filing Deadline, it is continuing to work closely with its Auditors to complete the necessary review and assessments, with a view to filing the Annual Filings at the earliest opportunity.
If the Annual Filings cannot be completed before the Regulatory Filing Deadline, the Company will not be able to file of the Interim Unaudited Financial Statements, MD&A and the related CEO and CFO Certificates for the First Quarter, ended June 30, 2021 (the "Interim Filings"), which are due to be filed by August 30, 2021; the filing of the Interim Filings will thus be delayed until after the Annual Filings have been completed.
About Aquarius Surgical Technologies Inc.
Aquarius Surgical Technologies is an exclusive provider of innovative, minimally invasive medical laser systems and consumables for multiple medical disciplines, principally in the field of urology. Solutions also include clinical education, service, support and maintenance. ASTI is focused on increasing the availability of services for patients, enhancing the quality of patient care, improving operationally efficiencies and reducing total operational costs.
For more information, please contact:
Lorne MacFarlane, CFO email@example.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Aquarius Surgical Technologies Inc.
View source version on accesswire.com:
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Monarch Mining Corporation3.8.2021 13:36:59 CEST | Press release
Monarch Mining Corporation Announces a $13.5 Million Financing With Investissement Québec
IM Cannabis Corp.3.8.2021 13:31:47 CEST | Press release
IMC Announces Results of its Annual General and Special Meeting of Shareholders
StageZero Life Sciences Ltd3.8.2021 13:27:16 CEST | Press release
StageZero Life Sciences Appoints Matthew J. Pietras as CFO and COO
Stabilis Energy3.8.2021 13:02:20 CEST | Press release
Stabilis Solutions and the Galveston Wharves Partner to Offer LNG Fueling Services for Marine Vessels
KOMO Plant Based Foods Inc.3.8.2021 12:01:52 CEST | Press release
Komo Plant Based Foods Announces DTC Eligibility
FireFox Gold Corp3.8.2021 11:32:20 CEST | Press release
FireFox Reports Significant Gold from First-Ever Drilling at the Saittavaara Prospect, on the Jeesiö Project in Northern Finland
Achieve Life Sciences, Inc.3.8.2021 11:31:49 CEST | Press release
Achieve Life Sciences to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 12, 2021
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom